These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3124939

  • 21. [Treatment of Paget's disease of bone with salmon calcitonin (author's transl)].
    Kuhlencordt F, Ringe JD, Kruse HP.
    Dtsch Med Wochenschr; 1981 Nov 27; 106(48):1620-3. PubMed ID: 7308002
    [Abstract] [Full Text] [Related]

  • 22. Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin.
    Rojanasathit S, Rosenberg E, Haddad JG.
    Lancet; 1974 Dec 14; 2(7894):1412-5. PubMed ID: 4140329
    [No Abstract] [Full Text] [Related]

  • 23. A comparison of the acute effects of subcutaneous and intranasal calcitonin.
    O'Doherty DP, Bickerstaff DR, McCloskey EV, Atkins R, Hamdy NA, Kanis JA.
    Clin Sci (Lond); 1990 Feb 14; 78(2):215-9. PubMed ID: 2155751
    [Abstract] [Full Text] [Related]

  • 24. Formation of neutralizing antibodies during intranasal synthetic salmon calcitonin treatment of Paget's disease.
    Levy F, Muff R, Dotti-Sigrist S, Dambacher MA, Fischer JA.
    J Clin Endocrinol Metab; 1988 Sep 14; 67(3):541-5. PubMed ID: 3410939
    [Abstract] [Full Text] [Related]

  • 25. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC, Harrison JE, Wilson DR.
    Can Med Assoc J; 1977 Nov 05; 117(9):1031-4. PubMed ID: 562231
    [Abstract] [Full Text] [Related]

  • 26. [Influence of porcine calcitonin in 3 healthy patients and in a female patient with Paget's disease].
    Aznar Reig A, Zamora Madaria E, Herrera Justiniano E, Rubio Rubio JM, Gómez San Millán M, Merchante C.
    Rev Iber Endocrinol; 1971 Nov 05; 18(107):419-42. PubMed ID: 5133441
    [No Abstract] [Full Text] [Related]

  • 27. [Hypocalcemia induced in patients with Paget's disease by nasal salmon calcitonin. Effects of anti-calcitonin salmine antibodies].
    Reginster JY, Almer S, Gaspar S, Albert A, Deroisy R, Franchimont P.
    Rev Rhum Mal Osteoartic; 1989 Jun 05; 56(7):563-7. PubMed ID: 2756322
    [No Abstract] [Full Text] [Related]

  • 28. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].
    Trzenschik K, Schmidt UJ, Abendroth K, Ansorg H, Graner H, Lindenhayn K, Schramm G, Kalbe I.
    Z Alternsforsch; 1978 Jun 05; 33(5):441-51. PubMed ID: 570764
    [Abstract] [Full Text] [Related]

  • 29. Effects of synthetic salmon calcitonin in patients with Paget's disease of bone.
    Hamilton CR.
    Am J Med; 1974 Mar 05; 56(3):315-22. PubMed ID: 4855941
    [No Abstract] [Full Text] [Related]

  • 30. Effect of salmon calcitonin on cardiac output, oxygen transport and bone turnover in patients with Paget's disease.
    Crosbie WA, Mohamedally SM, Woodhouse NJ.
    Clin Sci Mol Med Suppl; 1975 Jun 05; 48(6):537-40. PubMed ID: 1056285
    [Abstract] [Full Text] [Related]

  • 31. Treatment of Paget's disease with calcitonin.
    DeRose J, Avramides A, Baker RK, Wallach S.
    Semin Drug Treat; 1972 Jun 05; 2(1):51-5. PubMed ID: 5065517
    [No Abstract] [Full Text] [Related]

  • 32. Metabolic effects of synthetic salmon calcitonin in Paget's disease of bone.
    Avramides A, Baker RK, Wallach S.
    Metabolism; 1974 Nov 05; 23(11):1037-46. PubMed ID: 4472557
    [No Abstract] [Full Text] [Related]

  • 33. Efficacy and safety of drugs for Paget's disease of bone.
    Reginster JY, Lecart MP.
    Bone; 1995 Nov 05; 17(5 Suppl):485S-488S. PubMed ID: 8573423
    [Abstract] [Full Text] [Related]

  • 34. Synthetic salmon calcitonin. Treatment of Paget's disease and osteogenesis imperfecta.
    Goldfield EB, Braiker BM, Prendergast JJ, Kolb FO.
    JAMA; 1972 Sep 04; 221(10):1127-9. PubMed ID: 4679000
    [No Abstract] [Full Text] [Related]

  • 35. Paget's disease of the skull and migraine headache.
    Hamilton CR, Quesada O.
    Johns Hopkins Med J; 1973 Mar 04; 132(3):179-85. PubMed ID: 4266199
    [No Abstract] [Full Text] [Related]

  • 36. Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate.
    Delmas PD, Chapuy MC, Meunier PJ.
    Horm Metab Res; 1984 May 04; 16(5):258-61. PubMed ID: 6234216
    [Abstract] [Full Text] [Related]

  • 37. [The treatment of Paget's disease using salmon thyrocalcitonin. 8 cases (author's transl)].
    Deplante JP, Daumont A, Bouvier M, Lejeune E.
    Nouv Presse Med; 1978 Nov 25; 7(41):3753-6. PubMed ID: 733525
    [Abstract] [Full Text] [Related]

  • 38. Paget's disease of bone (osteitis deformans) treated with human synthetic calcitonin.
    Epstein S, Owen G.
    S Afr Med J; 1977 Jan 29; 51(5):133-7. PubMed ID: 850845
    [Abstract] [Full Text] [Related]

  • 39. Intranasal and intramuscular human calcitonin in female osteoporosis and in Paget's disease of bones: a pilot study.
    Pontiroli AE, Pajetta E, Calderara A, Alberetto M, Pozza G, Manganelli V, Resmini G, Tessari L, Maresca V.
    J Endocrinol Invest; 1991 Jan 29; 14(1):47-51. PubMed ID: 1646250
    [Abstract] [Full Text] [Related]

  • 40. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
    Ghiringhelli G, Fogel M, Varela de Rodríguez J, Casco C, Mautelén C, Nusimovich B.
    Medicina (B Aires); 1982 Jan 29; 42(1):16-20. PubMed ID: 6813634
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.